(19)
(11)
EP 1 155 021 A1
(12)
(43)
Date of publication:
21.11.2001
Bulletin 2001/47
(21)
Application number:
00904573.3
(22)
Date of filing:
26.01.2000
(51)
International Patent Classification (IPC)
7
:
C07F
9/06
,
C07D
311/04
,
A61K
9/00
,
A61K
31/66
,
A61K
31/35
(86)
International application number:
PCT/US0001/923
(87)
International publication number:
WO 0044/757
(
03.08.2000
Gazette 2000/31)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
27.01.1999
US 117567 P
01.02.1999
US 118198 P
(71)
Applicant:
Zielinski Laboratory
San Diego, CA 92121 (US)
(72)
Inventor:
ZIELINSKI, Jan, E.
Vista, CA 92083 (US)
(74)
Representative:
VOSSIUS & PARTNER
Siebertstrasse 4
81675 München
81675 München (DE)
(54)
HESPERITIN PRO-FORMS WITH ENHANCED BIOAVAILABILITY